Gregory Stock

Last updated
Gregory Stock
CitizenshipAmerican
Education Johns Hopkins University (BA, MSc, PhD)
Harvard Business School (MBA)

Gregory Stock is an American biophysicist, best-selling author, biotechnology entrepreneur, and the former director of the Program on Medicine, Technology and Society at UCLA School of Medicine. His interests lie in the scientific and evolutionary as well as ethical, social and political implications of today's revolutions in the life sciences and in information technology and computers.

Contents

Life, written works, and business career

Education

He received an MBA from Harvard Business School in 1987, where he was a Baker Scholar and won the Freund-Porter Entrepreneurship award. Stock completed a doctorate in biophysics from Johns Hopkins University in 1977, where he received a BA and MSc in 1971. [1]

Biotechnology and its impact on society

He has written extensively on the implications for society, medicine and business of the human genome project and associated developments in molecular genetics and bioinformatics. The Storefront Genome, [2] the symposium he convened in January 2003 to consider the broad challenges that cheap, easy access to our genetic constitutions drew wide media attention, and his 1998 look at the possibilities of manipulating the genetics of human embryos, the first major public discussion of this issue among distinguished scientists, opened a global debate on this then taboo topic. [3]

Biotechnology entrepreneur

Stock was the CEO of Signum Biosciences. [4] Signum Biosciences is a private biotechnology company dedicated to developing small-molecule therapeutics derived from its Signal Transduction Modulation (STM) platform to modulate signal transduction imbalances. Through research on protein networks that control biological systems, Signum is developing therapeutic candidates for Alzheimer's disease, Parkinson's, diabetes, asthma and certain skin conditions. Signum’s STM technology provides many opportunities for the development of novel consumer products and pharmaceutical candidates. Signum was founded on the science derived from basic research studying cellular signaling at the Princeton University laboratory of Dr. Jeffry Stock

He sits on the editorial board of the American Journal of Bioethics and is in the department of Pediatrics at the UCLA School of Medicine. [5] He is a member of the Board of Directors of Napo Pharmaceuticals, a pharmaceutical company headquartered in San Francisco. [6] He sits on the California Advisory Committee on Stem Cells and Reproductive Cloning and serves as the associate director for the Bioagenda Institute and the Center for Life Science Studies at the University of California at Berkeley.

Dr. Stock has been an invited speaker to many academic, government and business conferences. He makes regular appearances on television and radio, and has appeared on CNN, PBS, [7] NPR and the BBC in shows including Talk of the Nation, Charlie Rose, [8] Oprah Winfrey, Biotech Nation and Larry King.

Public policy and activities

Stock was an early force in considering the implications of human germline engineering and human enhancement. Through the Program on Medicine, Technology and Society, which he founded at the UCLA School of Medicine, he organized an influential 1998 conference at UCLA: "Engineering the Human Germline," which included a panel of James Watson, French Anderson, Lee Hood and other major figures in the life sciences. The event, which attracted considerable media attention and opened up broad debate on what was then a largely taboo topic, was covered on the front page of the New York Times. [9] Through another seminal UCLA conference, Milestones on Aging, he organized, Stock helped legitimize research to significantly extend human longevity. [10] The event led to a follow conference he co-hosted at UC Berkeley with Bruce Ames and Aubrey de Grey, who went on to found the Methuselah Foundation, an organization that has aggressively promoted research on life extension. The activity of the MTS Program was also critical in establishing UCLA’s Center on Society and Genetics, which actively explores broad policy issues in the genomics arena.

Stock is now primarily engaged in the development of new therapeutics at Signum Biosciences, a biotech company he co-founded in 2003, but he remains active in the policy arena through UCLA's MTS Program, which he still directs, and the BioAgenda Institute, [11] which he is the associate director of, and through various public appearances and debates. Stock has presented diverse keynotes ranging from “The Coming Era of Personalized Medicine” at Medco, “Trends in Health, Science and Nutrition” at the American Dietetic Association, "The Future of Genomics and Healthcare" at Johnson and Johnson, "The Coming Healthcare Revolution" at HIMS (Healthcare Information Management Society) and "The Evolution of the Biotech Revolution" at Applied Biosystems to "21st Century Opportunities and Challenges" at the World Future Society, "Beauty, Health and Biotech: A Look Ahead" at Fashion Group International, "Redesigning Humans: Best Hope, Worst Fear" at the TED (Technology, Education and Design) Conference, and "From Pharmacogenomics to Genetic Design" at the World Transhumanist Association. He has also been involved with broadcast media through guest appearances on shows such as the PBS documentary "Religion and Ethics: The Challenge and Ethics of Strong Biotechnology," debates on NPR's Talk of the Nation and Charlie Rose, via an online multimedia documentary he produced with funding from the Greenwall and Sloan Foundations entitled "Human Germline Engineering: Implications for Science and Society"(www.germline.ucla.edu), and in an ARTE documentary examining key figures in Biotechnology. [12] (he also has a nephew named Jake Posl)

Stock's expertise in biotechnology, genetics and public policy in the life sciences led to his appointment on the California Advisory Committee on Stem Cells and Reproductive Cloning, Dept. of Health Services, State of California. [13]

Debates

Stock has always been a strong advocate for the aggressive implementation of new technology in the life sciences and he has publicly debated many leading figures in the bioethics community, including Francis Fukuyama, Jeremy Rifkin, Leon Kass, [14] George Annas, Dan Callahan, [15] Bill McKibben, [16] Michael Sandel, [17] William Hurlbut and Nigel Cameron. [18] In these appearances, he has consistently argued against restrictions on life science research including funding bans on stem cell research, moratoriums on cloning, overly protective pharmaceutical regulatory controls, and efforts to constrain anti-aging research. A fellow of the World Technology Council and World Academy of Art and Science, Stock's argues in favor of the positive benefits of new technology has on human life and the role it will play on our future.

Books


Dr. Stock has written works on the impact and significance of recent advances in technology and the life sciences, and several bestsellers on values and ethics. His Book of Questions series, which consists of four eclectic collections of provocative situational dilemmas, was designed to generate discussion and thought about value-laden issues. The series has sold more than three million copies in total, been translated into 17 languages, and spawned a host of imitations. The original Book of Questions was number 1 on the New York Times Bestseller's list for 8 weeks.

His books on technology, public policy and future human evolution are:

Stock currently serves on the editorial Board of Rejuvination Science, the International Journal of Bioethics, [19] the Journal of Evolution and Technology, [20] and the American Journal of Bioethics. [21]

Boards

Selected articles

Related Research Articles

Bioethics is both a field of study and professional practice, interested in ethical issues related to health, including those emerging from advances in biology, medicine, and technologies. It proposes the discussion about moral discernment in society and it is often related to medical policy and practice, but also to broader questions as environment, well-being and public health. Bioethics is concerned with the ethical questions that arise in the relationships among life sciences, biotechnology, medicine, politics, law, theology and philosophy. It includes the study of values relating to primary care, other branches of medicine, ethical education in science, animal, and environmental ethics, and public health.

<span class="mw-page-title-main">Arthur Caplan</span> American bioethicist (born 1950)

Arthur L. Caplan is an American ethicist and professor of bioethics at New York University Grossman School of Medicine.

<span class="mw-page-title-main">Leon Kass</span> American academic (born 1939)

Leon Richard Kass is an American physician, scientist, educator, and public intellectual. Kass is best known as a proponent of liberal arts education via the "Great Books," as a critic of human cloning, life extension, euthanasia and embryo research, and for his tenure as chairman of the President's Council on Bioethics from 2001 to 2005. Although Kass is often referred to as a bioethicist, he eschews the term and refers to himself as "an old-fashioned humanist. A humanist is concerned broadly with all aspects of human life, not just the ethical."

<span class="mw-page-title-main">Designer baby</span> Genetically modified human embryo

A designer baby is a baby whose genetic makeup has been selected or altered, often to exclude a particular gene or to remove genes associated with disease. This process usually involves analysing a wide range of human embryos to identify genes associated with particular diseases and characteristics, and selecting embryos that have the desired genetic makeup; a process known as preimplantation genetic diagnosis. Screening for single genes is commonly practiced, and polygenic screening is offered by a few companies. Other methods by which a baby's genetic information can be altered involve directly editing the genome before birth, which is not routinely performed and only one instance of this is known to have occurred as of 2019, where Chinese twins Lulu and Nana were edited as embryos, causing widespread criticism.

The Council for Responsible Genetics (CRG) was a nonprofit NGO with a focus on biotechnology.

<span class="mw-page-title-main">Axel Kahn</span> French geneticist (1944–2021)

Axel Kahn was a French geneticist. He was the brother of the journalist Jean-François Kahn and the chemist Olivier Kahn. He was a member of the French National Consultative Ethics Committee from 1992 to 2004 and worked in gene therapy. He first entered the INSERM with a specialization in biochemistry. He was named in 2002 as a counsellor for biosciences and biotechnologies matters by the European Commission. Head of French laboratories specialized in biomedical sciences between years 1984 and 2007, he was elected President of the Paris Descartes University in December 2007, as the sole candidate.

Linda MacDonald Glenn is an American bioethicist, healthcare educator, lecturer, consultant, and attorney-at-law. Her academic research encompasses the legal, ethical, and social impact of emerging and exponential technologies and "evolving notions of personhood".

<span class="mw-page-title-main">Celltech</span> Former British-based biotechnology firm

Celltech Group plc was a leading British-based biotechnology business based in Slough. It was listed on the London Stock Exchange and was a constituent of the FTSE 100 Index. Celltech was instrumental in changing the UK's system of technology transfer from research to business, and in creating the biotechnology industry.

The Center for Genetics and Society (CGS) is a non-profit information and public affairs organization based in Berkeley, California, United States. It encourages the responsible use and regulation of new human genetic and reproductive technologies. CGS provides analysis and educational materials and organizes conferences, workshops, and briefings. This organization tends to particularly criticize proposals concerning reproductive human cloning and germline genetic modification—both uses of technology colloquially considered 'socially irresponsible.'

This page provides an alphabetical list of articles and other pages about biotechnology.

The Institute on Biotechnology and the Human Future (IBHF) is an affiliate of the Illinois Institute of Technology (IIT) and is housed at IIT's Chicago-Kent College of Law. The IBHF was founded in 2004 by Lori Andrews, J.D., and Nigel M. de S. Cameron, Ph.D., to discuss and analyze the ethical, legal, and social implications of biotechnologies.

The International Bioethics Committee (IBC) of UNESCO is a body composed of 36 independent experts from all regions and different disciplines that follows progress in the life sciences and its applications in order to ensure respect for human dignity and human rights. It was created in 1993 by Dr Federico Mayor Zaragoza, General Director of UNESCO at that time. It has been prominent in developing Declarations with regard to norms of bioethics that are regarded as soft law but are nonetheless influential in shaping the deliberations, for example, of research ethics committees and health policy.

<span class="mw-page-title-main">Cumberland School of Law's Center for Biotechnology, Law, and Ethics</span>

The Center for Biotechnology, Law and Ethics is a bioethics, biotechnology, and biotechnology law research center of Cumberland School of Law located on the Samford University campus in Birmingham, Alabama. It is one of the few research centers of its kind at a United States law school, and, in conjunction with the Cumberland Law Review, the Center publishes an annual journal of scholarly works, which circulates in the United States and foreign countries.

The Nuffield Council on Bioethics is a UK-based independent charitable body, which examines and reports on bioethical issues raised by new advances in biological and medical research. Established in 1991, the Council is funded by the Nuffield Foundation, the Medical Research Council and the Wellcome Trust. The Council has been described by the media as a 'leading ethics watchdog', which 'never shrinks from the unthinkable'.

<span class="mw-page-title-main">Christoph Rehmann-Sutter</span>

Christoph Rehmann-Sutter is a philosopher and bioethicist. He is holding a professorship for theory and ethics in biosciences at the Institute for History of Medicine and Science Studies at the University of Lübeck in Germany.

<span class="mw-page-title-main">I. Glenn Cohen</span>

I. Glenn Cohen is a Canadian legal scholar and professor at Harvard Law School. He is also the director of Harvard Law School's Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics.

A biological patent is a patent on an invention in the field of biology that by law allows the patent holder to exclude others from making, using, selling, or importing the protected invention for a limited period of time. The scope and reach of biological patents vary among jurisdictions, and may include biological technology and products, genetically modified organisms and genetic material. The applicability of patents to substances and processes wholly or partially natural in origin is a subject of debate.

Human germline engineering (HGE) is the process by which the genome of an individual is modified in such a way that the change is heritable. This is achieved by altering the genes of the germ cells, which mature into eggs and sperm. For safety, ethical, and social reasons, the scientific community and the public have concluded that germline editing for reproduction is inappropriate. HGE is prohibited by law in more than 70 countries and by a binding international treaty of the Council of Europe.

<span class="mw-page-title-main">John Kilner</span>

John F. Kilner is a bioethicist who held the Franklin and Dorothy Forman endowed chair in ethics and theology at Trinity International University, where he was also Professor of Bioethics and Contemporary Culture and Director of Bioethics Degree Programs. He is a Senior Fellow at The Center for Bioethics & Human Dignity (CBHD) in Deerfield, Illinois, where he served as Founding Director until Fall 2005.

<span class="mw-page-title-main">Vardit Ravitsky</span> Bioethicist, researcher, and author

Vardit Ravitsky, an Israeli-Canadian, is a bioethicist, researcher, and author. She is president and CEO of The Hastings Center, a senior lecturer on Global Health and Social Medicine at Harvard Medical School, and past president of the International Association of Bioethics. She is a Fellow of the Pierre Elliott Trudeau Foundation, where she chaired the COVID-19 Impact Committee. She is also a Fellow of The Hastings Center and of the Canadian Academy of Health Sciences. Previously, she was a full professor at the University of Montreal, and director of Ethics and Health at the Center for Research on Ethics.

References

  1. UCLA Website: Gregory Stock Archived 2008-08-21 at the Wayback Machine
  2. The Storefront Genome Archived 2010-07-06 at the Wayback Machine
  3. Stock, Gregory (2004-07-06). "From Regenerative Medicine to Human Design: What Are We Really Afraid Of?". DNA and Cell Biology. 22 (11): 679–683. doi:10.1089/104454903770946656. PMID   14659040.
  4. Signum Biosciences Archived 2009-03-21 at the Wayback Machine
  5. UCLA Center for Society and Genetics Archived 2009-04-18 at the Wayback Machine
  6. Napo Pharmaceuticals Archived 2011-02-15 at the Wayback Machine
  7. "August 17, 2007 ~ Gregory Stock | August 17, 2007 | Religion & Ethics NewsWeekly | PBS". Religion & Ethics NewsWeekly. 2007-08-17. Retrieved 2018-03-23.
  8. Gregory Stock on Charlie Rose Archived 2012-02-21 at the Wayback Machine
  9. Gina Kolata for the New York Times. March 21, 1998 Scientists Brace for Changes In Path of Human Evolution
  10. Alliance for Aging Research Archived 2008-11-26 at the Wayback Machine
  11. "BioAgenda". www.bioagendaprograms.com. Retrieved 2018-03-23.
  12. Engineering the Human Germline Symposium Archived 2008-05-13 at the Wayback Machine
  13. "Human Stem Cell Research Advisory Committee Information". Archived from the original on 2009-05-28. Retrieved 2009-05-01.
  14. "Biotechnology". NPR.org. Retrieved 2018-03-23.
  15. Edmonton Aging Symposium Presentation
  16. "New website features live webcast with Dr. Gregory Stock and Bill McKibben". www.scienceblog.com. Retrieved 2018-03-23.
  17. "Resources -- Articles". humanitas.org. Retrieved 2018-03-23.
  18. The BioAgenda 2007 Great Debate: Should the world permanently ban the genetic manipulation of human embryos – yes or no?
  19. "Ethics & Medicine – International Journal of Bioethics". www.ethicsandmedicine.com. Retrieved 2018-03-23.
  20. "JET Editorial Board". www.jetpress.org. Retrieved 2018-03-23.
  21. "Journal Backs Verification of Cloning Work in Wake of Scandal | Bioethics.net". www.bioethics.net. Retrieved 2018-03-23.
  22. Signum Biosciences Inc Board of Directors Archived 2009-03-22 at the Wayback Machine
  23. Napo Pharmaceuticals Board of Directors Archived 2011-02-15 at the Wayback Machine